Session Learning Objectives

Pharmacology Preconference

Medication Management of Excess Weight and Co-Morbid Conditions

    1. Review National Guidelines for the Management of Obesity and the recommendations regarding pharmacotherapy in relationship to behavioral interventions and surgical procedures.
    2. List FDA approved medications for weight management and their approved dosing, schedule, adverse effects and contraindications.
    3. Describe, using case examples, how to match patients with co-morbid conditions to safe and effective weight management therapies.

Anti-Hyperglycemic Therapies: Improving CVD Outcomes

    1. Describe the new challenge for cardiology in prescribing medications to manage diabetes as well as CVD.
    2. Review recent clinical trials of anti-hyperglycemic therapies, CV outcomes and impact on FDA indications.
    3. Discuss appropriate antihyperglycemic therapy selection, dose and potential side effects in selected case studies.

Medications to Manage Rate, Rhythm and Symptoms Associated with Atrial Fib and Flutter

    1. List common medications used to control heart rate in patients with atrial fib and flutter along with appropriate dose, schedule, adverse effects and contraindications.
    2. Describe the role of medications in cardioversion and maintenance of sinus rhythm in patients with atrial fib and flutter along with appropriate dose, schedule, adverse effects and contraindications.
    3. Review common symptoms associated with atrial fib and flutter and discuss the impact of heart rate and rhythm control therapies on these symptoms.

General Sessions

Thursday, April 5

Cardiovascular Risk Reduction and LDL-C: Evolving Perspectives

    1. Increased awareness of recent evidence further supporting the relationship between lowering LDL-C and ASCVD risk.
    2. Greater confidence in utilizing nonstatin therapies that lower LDL-C well below current targets and demonstrate net ASCVD risk-reduction benefit.
    3. Implementation of updated, recommended algorithms for LDL-lowering with non-statin therapies to further reduce ASCVD risk.
    4. Increased attainment of LDL-C treatment goals in vulnerable patient populations.

Opening Keynote: Big Data and the Future of Cardiovascular Disease Prevention and Treatment

    1. Describe how the advances in big data management and analysis can effectively translate to improved cardiovascular health care.
    2. Review and provide “best practice” examples for incorporating big data in the care of patients with cardiovascular disease.

Genetic Counseling and Inherited CVD: A Family Affair

    1. Briefly review definitions of terms pertinent to the science of genetics/genomics.
    2. Describe the landscape of genetic counseling as it relates to inherited cardiovascular disorders: cardiomyopathy, heart rhythm disorders, FH, vascular disease.
    3. Using a case study, illustrate the collaborative relationship between genetics counselor, nurses, other clinicians, and families.

Pediatric Prevention Guidelines: It's Never Too Early (or Too Late) to Focus on Heart Health

    1. Review current guidelines regarding CVD risk management in children and adolescents.
    2. List practical strategies to instill heart healthy behaviors in children, families, schools and communities.

Skill Building Sessions

Don't Sleep On It! Integrating Sleep Assessments and Treatments in Your CVD Practice

      1. Outline the relationship between sleep disorders and CVD.
      2. Demonstrate how to perform a sleep assessment.
      3. Provide and overview of diagnostic tests and treatments for common sleep disorders.
      4. Describe strategies to ensure effectiveness and adherence to various treatments for disordered sleep.

CVD Imaging: A Primer in Test Selection, Interpretation and Application

      1. Review common imaging studies used to evaluate CVD including ischemia and coronary disease.
      2. Describe, using case examples, the application of CVD imaging based on patient characteristics, symptoms or co-morbid conditions.
      3. List practical approaches to interpretation of common CVD imaging studies and their associated reports.

It's Easy Being Green: Lifestyle Medicine and Plant-Based Diets

    1. Review the role of a plant-based diet on blood cholesterol and other CVD risk factors.
    2. Describe practical strategies for counseling patients in a lifestyle approach to managing CVD risks.

Friday, April 6

Undiagnosed Non-Valvular Atrial Fibrillation and Stroke Risk: A Call to Action

    1. Discuss the magnitude of undiagnosed non-valvular atrial fibrillation (NVAF) in the population at large and review common risk factors.
    2. Summarize the stroke risks associated with NVAF and available treatments to prevent stroke.
    3. Describe atrial fibrillation awareness and screening tools and provide examples of activities that can be executed in a variety of clinical and community settings.
    4. Review risk communication strategies to help patients and care givers understand risks and benefits of NVAF treatment to actively engage in shared decision making.

The Weight of the World: Reducing Stroke and CVD Disparities

    1. Explain global burden and trends in CVD and Stroke incidence.
    2. Describe global strategies for primary prevention of CVD and stroke.

New Hypertension Guidelines: Matching Risks and Treatments

    1. Review current national guidelines regarding the definition of hypertension including new targets for treatment with lifestyle and medications.
    2. Discuss the clinical application of the national hypertension guidelines for special populations including the elderly and those with co-morbid conditions.
    3. Describe key strategies to improve patient adherence to anti-hypertensive treatments including lifestyle and medications.

Managing CVD Risks in Older Adults: Lessons from a Geriatric Cardiology Practice

    1. Describe the unique challenges in preventing and treating CVD in older adults.
    2. Review current evidenced-based recommendations for medication and lifestyle management of CVD in the older adult.

Breakout Sessions

Palliative Care: Ensuring Quality of Life Across the Spectrum of CVD

      1. Define palliative care as it applies to patients with advanced CVD, stroke and heart failure.
      2. Describe the relationship between palliative care and quality of life.
      3. Demonstrate communication strategies such as shared-decision making as it is applied to advanced care planning and management of physical, emotional and psychological distress.

Managing Atrial Fibrillation: Devices and Interventions

      1. Briefly review the prevalence, signs, symptoms and risks associated with atrial fibrillation.
      2. Describe non-pharmacologic treatments for acute and chronic atrial fibrillation including loop recorders and pacing devices, catheter ablation, and left atrial appendage closure interventions.
      3. Using a case-based approach, outline how shared-decision making is used to individualize treatment in patients with a fib.

Cardio-Renal Syndrome: Managing Risk and Treating Disease

      1. Define cardio-renal syndrome and describe the pathophysiology that drives the cardiorenal connection.
      2. Review the risk factors and biomarkers associated with cardio-renal syndrome.
      3. Using a case-based approach describe best practices for the management of patients with acute and chronic cardio-renal syndrome.

Saturday, April 7

CVD Risk Stratification and a Life-Course Perspective on Risk Communication

    1. Review both traditional and novel methods to predict future CVD.
    2. Describe how estimation of lifetime risk and risk-adjusted age impacts health behavior change and adherence to therapy.

Cardiac Rehab in 2018: Incorporating New Populations and Approaches

    1. Describe current national guidelines and outcomes for cardiac rehab and supervised exercise programming for patients with CVD, heart failure and PAD.
    2. Provide examples of exercise training strategies for patient with heart failure and PAD and how they can be incorporated into traditional cardiac rehab programs.

Closing Keynote:Caring for Ourselves, so We Can Care for Others

    1. Identify common causes of burnout among nurses.
    2. Discuss the ethical mandate for nurses to invest in their own well being.
    3. Identify 3 specific strategies for cultivating resilience.